Rite Aid Corp RADCQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RADCQ is a good fit for your portfolio.
News
-
Rite Aid Announces Availability of Opill at All Locations
-
Rite Aid Becomes Copia’s First Retail Pharmacy Partner to Help Combat Food Waste and Support Communities
-
Rite Aid Enters into Agreement to Divest Majority of Health Dialog Assets
-
Rite Aid and Bartell Drugs Announce Additional Dose of Updated COVID-19 Vaccine Available for Customers Ages 65 and Older
-
Rite Aid Unveils New ‘It Means More’ Ad Spot, Showcasing Unwavering Commitment to Serving and Supporting Its Customers
-
Rite Aid Completes Sale of Elixir Solutions to MedImpact
-
Find Your ‘Perfect Pairing’ at Rite Aid this Valentine's Day
-
Rite Aid Banned From Using AI Facial Recognition in FTC Settlement
Trading Information
- Previous Close Price
- $0.07
- Day Range
- $0.04–0.09
- 52-Week Range
- $0.00–3.16
- Bid/Ask
- $0.36 / $0.40
- Market Cap
- $2.83 Mil
- Volume/Avg
- 9,539 / 126,118
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Stock Style Box
- Small Value
- Total Number of Employees
- 47,000
- Website
- https://www.riteaid.com
Competitors
Valuation
|
Metric
|
RADCQ
|
VWAGY
|
CVS
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 3.96 | 7.69 |
Price/Book Value | — | 0.42 | 1.13 |
Price/Sales | — | 0.21 | 0.24 |
Price/Cash Flow | — | 1.43 | 6.46 |
Price/Earnings
RADCQ
VWAGY
CVS
Financial Strength
|
Metric
|
RADCQ
|
VWAGY
|
CVS
|
|---|---|---|---|
Quick Ratio | 0.24 | 0.92 | 0.59 |
Current Ratio | 0.57 | 1.22 | 0.86 |
Interest Coverage | −5.32 | — | 5.20 |
Quick Ratio
RADCQ
VWAGY
CVS
Profitability
|
Metric
|
RADCQ
|
VWAGY
|
CVS
|
|---|---|---|---|
Return on Assets (Normalized) | −8.26% | 3.21% | 4.62% |
Return on Equity (Normalized) | — | 11.99% | 15.38% |
Return on Invested Capital (Normalized) | −7.16% | 5.26% | 8.77% |
Return on Assets
RADCQ
VWAGY
CVS
Pharmaceutical Retailers Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
WBA
| Walgreens Boots Alliance Inc | Cfpfwphh | Tdygk | $15.2 Bil | |
RADLY
| Raia Drogasil SA ADR | — | Qwjls | $8.3 Bil | |
ALBBY
| Alibaba Health Information Technology Ltd ADR | — | Jffyykh | $6.1 Bil | |
ALBHF
| Alibaba Health Information Technology Ltd | — | Flsfxk | $6.1 Bil | |
CLCGY
| Clicks Group Ltd ADR | — | Whsjys | $3.6 Bil | |
TSUSF
| Tsuruha Holdings Inc | — | Lynly | $3.1 Bil | |
SGIPF
| Sugi Holdings Co Ltd | — | Wmyg | $2.8 Bil | |
SAEYY
| Redcare Pharmacy NV ADR | — | Xhvd | $2.7 Bil | |
SHPPF
| Redcare Pharmacy NV | — | Ckyk | $2.5 Bil | |
ZRSEF
| DocMorris AG | — | Prs | $1.1 Bil |